Alexion files for key drug with priority review voucher Trust favourite Alexion Pharmaceuticals (Nasdaq: ALXN) yesterday confirmed it had made a US regulatory submission for approval of ALXN1210, its long-acting C5 complement inhibitor, for the treatment of the ultra-rare condition of paroxysmal nocturnal hemoglobinuria (PNH). Alexion is a cornerstone holding for both the OrbiMed-managed Biotech Growth Trust […]
FDA fast track review for trust-backed Sage Therapeutics Sage Therapeutics (Nasdaq: SAGE), a high conviction idea for two of the biotech sector specialist investment trusts, has confirmed that the US FDA has accepted the NDA filing for its lead product, brexanolone IV for treatment of postpartum (post natal) depression (PPD), and granted the application priority review status. NDA […]
Fidelity Closed end fund review – March 2018 – is a regular publication looking at Fidelity and recent developments in three of its investment trusts – Fidelity Asian Values, Fidelity Japanese Values and Fidelity Special Values. In this issue: Fidelity Asian Values (FAS) posted decent positive returns during 2017 but has continued to lag its peer […]
Fidelity Closed-End Funds Review – Marten & Co is publishing a new Fidelity Closed-End Funds review. This covers funds in the Asia-Pacific ex-japan, Japanese Smaller Companies and UK All Companies sectors. Welcome to the fifth edition of Marten & Co’s Fidelity Closed-End Funds Review – a regular publication looking at Fidelity and recent developments in three of its investment trusts – Fidelity Asian […]
Ranger Direct Board asks Kinmont to review management arrangements – Ranger Direct Lending put in place a management contract at the time of its IPO with Ranger Alternative Management II, LP. The initial term finishes on 1 May 2018 and then there is a rolling one year notice period thereafter. On 1 November 2017, the Board announced that it, in conjunction […]
QuotedData – 2017 review of the year – Many commentators, including us, were wary going into 2017. In the event, economic growth and markets surprised on the upside: US markets hit new highs despite three interest rate rises. Perceived low/no growth areas such as Europe and Japan burst into life. Asia’s technology stocks surged. India’s […]
Marten & Co is publishing a new Fidelity Closed-End Funds review. This covers funds in the Asia-Pacific ex-japan, Japanese Smaller Companies and UK All Companies sectors. Welcome to the fourth edition of QuotedData’s Fidelity Closed-End Funds Review – a regular publication looking at Fidelity and recent developments in three of its investment trusts – Fidelity Asian Values, Fidelity Japanese Values and Fidelity Special Values. In […]
Fidelity Closed-End Funds Review Welcome to the third edition of Marten & Co’s Fidelity Closed-End Funds Review – a regular publication looking at Fidelity and recent developments in three of its investment trusts – Fidelity Asian Values, Fidelity Japanese Values and Fidelity Special Values. In this issue: The appointment of Nitin Bajaj as manager of Fidelity Asian […]
P2P Global’s board say that “2016 was a year of significant challenges, both for the company and its markets. The Board of the company has announced a review of its investment management arrangements, following a year of disappointing performance both on dividend yield and share price. The Board expects to update shareholders on the outcome […]
P2P Global Investments says that it is conducting a review of its investment management arrangements. Following discussions with MW Eaglewood Europe LLP (the investment manager) and significant shareholders of the company, the board has resolved to initiate a review of the company’s investment management arrangements. The board will update shareholders as to the outcome of the […]
